NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ucello Biotechnology

Ucello Biotechnology

Private
ChengduHealthcare & Life Scienceshttp://www.ucello.cn/

Last Round

Series A

Extension

Jun 2, 2023

Est. Valuation

$105.8M

Total Funding Raised

$77.74M

Company Overview

Ucello Biotechnology is a biotechnology company that specializes in the research, development, and commercialization of allogeneic universal CAR-T cell therapeutic drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

recombinant proteinsin vitro diagnosticIVDdiagnostic raw materialsCAR-T cell therapybiological reagentsbiopharmaceuticalallogeneic cell therapymolecular biology reagentsprotein purificationbiotech supply chainlife science reagentslab suppliescell therapy manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ucello Biotechnology Comparables

Compare Ucello Biotechnology with similar companies based on industry and business-model similarity.

Ucello Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qihan Biotech
86%
BRL Medicine Inc.
81%
Bioheng Therapeutics
80%

Ucello Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJun 2, 2023
Series CAug 11, 2022
Series AFeb 10, 2022
Series BMar 30, 2021
Series AOct 18, 2018
Angel
Mar 1, 2016

Ucello Biotechnology Investors

Notable investors and investment history

Ucello Biotechnology investors
InvestorRounds
Co-Win VenturesSeries A Extension, Series A, Angel
Northern Light Venture CapitalSeries A, Angel
Shenzhen Guozhong Venture Capital ManagementSeries A Extension
MPCSeries A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2016

    $15.4M raised in an Angel round.

Ucello Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ucello Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ucello Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersChengdu
Year Founded2020
Last FundingJun 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.